Sunitinib for adenocarcinoma of the rete testis: a case report
BackgroundAdenocarcinoma of the rete testis (AORT) is an extremely rare and aggressive tumor with a poor prognosis. Its etiology and pathological characteristics have not been extensively studied, making accurate diagnosis and appropriate management challenging. AORT, an invasive testicular tumor wi...
Main Authors: | Kezhen Li, Di Chen, Mingdong He, Jun Yu, Hua Mi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1358133/full |
Similar Items
-
Sunitinib in pancreatic neuroendocrine tumors. Clinical case
by: A. A. Markovich, et al.
Published: (2019-12-01) -
Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment
by: Kouki Tada, et al.
Published: (2023-01-01) -
Photochemically-Induced Release of Lysosomal Sequestered Sunitinib: Obstacles for Therapeutic Efficacy
by: Judith Jing Wen Wong, et al.
Published: (2020-02-01) -
Vogt-Koyanagi-Harada-Like Disease with Loss of Visual Acuity due to Sunitinib Treatment Restored after Switch in Therapy: A Case Report
by: Mechteld C.S. van Olden, et al.
Published: (2024-03-01) -
Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study
by: Haohao Lu, et al.
Published: (2023-03-01)